Skip to main content
SpringerLink
Log in

Prognostic Assessment by Noninvasive Imaging. Part a. Clinical Decision-making in Patients with Suspected or Known Coronary Artery Disease

  • Chapter
Noninvasive Imaging of Myocardial Ischemia

  • 629 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berman DS, Hachamovitch R, Shaw LJ, Hayes SW, Germano G. Nuclear cardiology. In: Fuster VAR, O’Rourke RA, Roberts R, King SB, Wellens HJJ, eds. Hurst’s The Heart. 11th ed. New York: McGraw-Hill; 2004.

    Google Scholar 

  2. Ladenheim ML, Kotler TS, Pollock BH, Berman DS, Diamond GA. Incremental prognostic power of clinical history, exercise electrocardiography and myocardial perfusion scintigraphy in suspected coronary artery disease. Am J Cardiol 1987;59:270–277.

    Article  PubMed  CAS  Google Scholar 

  3. Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995;26:639–647 [published erratum appears in J Am Coll Cardiol 1996;27(3):756].

    Article  PubMed  CAS  Google Scholar 

  4. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905–914.

    PubMed  CAS  Google Scholar 

  5. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535–543.

    PubMed  CAS  Google Scholar 

  6. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900–2907.

    Article  PubMed  Google Scholar 

  7. Marwick TH, Shaw LJ, Lauer MS, et al. The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group. Am J Med 1999;106:172–178.

    Article  PubMed  CAS  Google Scholar 

  8. Sharir T, Germano G, Kang XP, Cohen I, Friedman JD, Berman DS. Prognostic value of post-stress left ventricular volume and ejection fraction by gated myocardial perfusion single photon emission computed tomography in women: gender related differences in normal limits and outcome [abstract]. Circulation 2002;106:II–523.

    Google Scholar 

  9. Zellweger MJ, Lewin HC, Lai S, et al. When to stress patients after coronary artery bypass surgery? Risk stratification in patients early and late post-CABG using stress myocardial perfusion SPECT: implications of appropriate clinical strategies. J Am Coll Cardiol 2001;37:144–152.

    Article  PubMed  CAS  Google Scholar 

  10. Sharir T, Germano G, Kang X, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 2001;42:831–837.

    PubMed  CAS  Google Scholar 

  11. Sharir T, Berman DS, Lewin HC, et al. Incremental prognostic value of rest-redistribution Tl-201 single-photon emission computed tomography. Circulation 1999;100:1964–1970.

    PubMed  CAS  Google Scholar 

  12. Travin MI, Heller GV, Johnson LL, et al. The prognostic value of ECG-gated SPECT imaging in patients undergoing stress Tc-99m sestamibi myocardial perfusion imaging. J Nucl Cardiol 2004;11:253–262.

    Article  PubMed  Google Scholar 

  13. Thomas GS, Miyamoto MI, Morello AP, et al. Technetium99m based myocardial perfusion imaging predicts clinical outcome in the community outpatient setting: the nuclear utility in the community (“nuc”) study. J Am Coll Cardiol 2004;43:213–223.

    Article  PubMed  Google Scholar 

  14. Moir S, Haluska BA, Jenkins C, Fathi R, Marwick TH. Incremental benefit of myocardial contrast to combined dipyridamole-exercise stress echocardiography for the assessment of coronary artery disease. Circulation 2004;110:1108–1113.

    Article  PubMed  CAS  Google Scholar 

  15. Hachamovitch R, Schnipper J, Young-Xu Y. Are patients with known or suspected coronary artery disease and normal stress imaging studies at low risk for adverse outcomes? Meta-analysis of stress echocardiography and SPECT. J Am Coll Cardiol 2000.

    Google Scholar 

  16. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). Circulation 2003;108:1404–1418.

    Article  PubMed  Google Scholar 

  17. Bateman TM. Clinical relevance of a normal myocardial perfusion scintigraphic study. American Society of Nuclear Cardiology. J Nucl Cardiol 1997;4:172–173.

    Article  PubMed  CAS  Google Scholar 

  18. Heller GV, Herman SD, Travin MI, Baron JI, Santos-Ocampo C, McClellan JR. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol 1995;26:1202–1208.

    Article  PubMed  CAS  Google Scholar 

  19. Shaw L, Chaitman BR, Hilton TC, et al. Prognostic value of dipyridamole thallium-201 imaging in elderly patients [comment]. J Am Coll Cardiol 1992;19:1390–1398.

    PubMed  CAS  Google Scholar 

  20. Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol 1994;73:647–652.

    Article  PubMed  CAS  Google Scholar 

  21. Calnon DA, McGrath PD, Doss AL, Harrell FE Jr, Watson DD, Beller GA. Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population [comment]. J Am Coll Cardiol 2001;38:1511–1517.

    Article  PubMed  CAS  Google Scholar 

  22. Kang X, Berman DS, Lewin HC, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999;138:1025–1032.

    Article  PubMed  CAS  Google Scholar 

  23. Amanullah AM, Kiat H, Friedman JD, Berman DS. Adenosine technetium-99m sestamibi myocardial perfusion SPECT in women: diagnostic efficacy in detection of coronary artery disease. J Am Coll Cardiol 1996;27:803–809.

    Article  PubMed  CAS  Google Scholar 

  24. Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol 2003;41:1329–1340.

    Article  PubMed  Google Scholar 

  25. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539–542.

    Article  PubMed  Google Scholar 

  26. Berman DS, Abidov A, Kang X, et al. Prognostic validation of a 17-segment score derived from a 20-segment score for myocardial perfusion SPECT interpretation. J Nucl Cardiol 2004;11:414–423.

    Article  PubMed  Google Scholar 

  27. Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002;105:32–40.

    Article  PubMed  Google Scholar 

  28. Hachamovitch R, Berman DS, Kiat H, Cohen I, Friedman JD, Shaw LJ. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness. Circulation 2002;105:823–829.

    Article  PubMed  Google Scholar 

  29. Vanzetto G, Ormezzano O, Fagret D, Comet M, Denis B, Machecourt J. Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: study in 1137 patients with 6-year follow-up. Circulation 1999;100:1521–1527.

    PubMed  CAS  Google Scholar 

  30. Berman DS, Kang X, Hayes SW, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003;41:1125–1133.

    Article  PubMed  Google Scholar 

  31. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998;32:57–62.

    Article  PubMed  CAS  Google Scholar 

  32. Abidov A, Hachamovitch R, Rozanski A, et al. Prognostic implications of atrial fibrillation in patients undergoing myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 2004;44:1062–1070.

    Article  PubMed  Google Scholar 

  33. Shaw LJ, Hendel RC, Borges-Neto S, et al. Prognostic value of normal exercise and adenosine (99m)Tctetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. J Nucl Med 2003;44:134–139.

    PubMed  Google Scholar 

  34. Albro PC, Gould KL, Westcott RJ, Hamilton GW, Ritchie JL, Williams DL. Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial. Am J Cardiol 1978;42:751–760.

    Article  PubMed  CAS  Google Scholar 

  35. Weiss AT, Berman DS, Lew AS, et al. Transient ischemic dilation of the left ventricle on stress thallium-201 scintigraphy: a marker of severe and extensive coronary artery disease. J Am Coll Cardiol 1987;9:752–759.

    Article  PubMed  CAS  Google Scholar 

  36. Mazzanti M, Germano G, Kiat H, et al. Identification of severe and extensive coronary artery disease by automatic measurement of transient ischemic dilation of the left ventricle in dual-isotope myocardial perfusion SPECT. J Am Coll Cardiol 1996;27:1612–1620.

    Article  PubMed  CAS  Google Scholar 

  37. Chouraqui P, Rodrigues EA, Berman DS, Maddahi J. Significance of dipyridamole-induced transient dilation of the left ventricle during thallium-201 scintigraphy in suspected coronary artery disease. Am J Cardiol 1990;66:689–694.

    Article  PubMed  CAS  Google Scholar 

  38. Abidov A, Bax JJ, Hayes SW, et al. Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J Am Coll Cardiol 2003;42:1818–1825.

    Article  PubMed  Google Scholar 

  39. Gill JB, Ruddy TD, Newell JB, et al. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med 1987;317:1486–1489.

    Article  PubMed  CAS  Google Scholar 

  40. Hansen CL, Sangrigoli R, Nkadi E, et al. Comparison of pulmonary uptake with transient cavity dilation after exercise thallium-201 perfusion imaging. J Am Coll Cardiol 1999;33:1323–1327.

    Article  PubMed  CAS  Google Scholar 

  41. Giubbini R, Campini R, Milan E, et al. Evaluation of technetium-99m-sestamibi lung uptake: correlation with left ventricular function. J Nucl Med 1995;36:58–63.

    PubMed  CAS  Google Scholar 

  42. Hurwitz GA, Fox SP, Driedger AA, Willems C, Powe JE. Pulmonary uptake of sestamibi on early post-stress images: angiographic relationships, incidence and kinetics. Nucl Med Commun 1993;14:15–22.

    PubMed  CAS  Google Scholar 

  43. Hurwitz GA, Ghali SK, Husni M, et al. Pulmonary uptake of technetium-99m-sestamibi induced by dipyridamole-based stress or exercise. J Nucl Med 1998;39:339–345.

    PubMed  CAS  Google Scholar 

  44. Bacher-Stier C, Kavanagh PB, Sharir T, et al. Post-exercise Tc-99m sestamibi lung uptake determined by a new automatic technique [abstract]. J Nucl Med 1998;39:104P.

    Google Scholar 

  45. Marshall ES, Raichlen JS, Kim SM, et al. Prognostic significance of ST-segment depression during adenosine perfusion imaging. Am Heart J 1995;130:58–66.

    Article  PubMed  CAS  Google Scholar 

  46. Hachamovitch R, Berman DS, Kiat H, et al. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol 1997;80:426–433.

    Article  PubMed  CAS  Google Scholar 

  47. Chikamori T, Doi YL, Yamada M, Takata J, Yonezawa Y, Ozawa T. Prognostic value of dipyridamole thallium scintigraphy in patients with coronary artery disease treated medically. Jpn Circ J 1993;57:851–861.

    PubMed  CAS  Google Scholar 

  48. Abbott BG, Afshar M, Berger AK, Wackers FJ. Prognostic significance of ischemic electrocardiographic changes during adenosine infusion in patients with normal myocardial perfusion imaging. J Nucl Cardiol 2003;10:9–16.

    Article  PubMed  Google Scholar 

  49. Klodas E, Miller TD, Christian TF, Hodge DO, Gibbons RJ. Prognostic significance of ischemic electrocardiographic changes during vasodilator stress testing in patients with normal SPECT images. J Nucl Cardiol 2003;10:4–8.

    Article  PubMed  Google Scholar 

  50. Lette J, Bertrand C, Gossard D, et al. Long-term risk stratification with dipyridamole imaging. Am Heart J 1995;129:880–886.

    Article  PubMed  CAS  Google Scholar 

  51. Amanullah AM, Berman DS, Erel J, et al. Incremental prognostic value of adenosine myocardial perfusion single-photon emission computed tomography in women with suspected coronary artery disease. Am J Cardiol 1998;82:725–730.

    Article  PubMed  CAS  Google Scholar 

  52. Stratmann HG, Younis LT, Kong B. Prognostic value of dipyridamole thallium-201 scintigraphy in patients with stable chest pain. Am Heart J 1992;123:317–323.

    Article  PubMed  CAS  Google Scholar 

  53. Amanullah AM, Berman DS, Kiat H, Friedman JD. Usefulness of hemodynamic changes during adenosine infusion in predicting the diagnostic accuracy of adenosine technetium-99m sestamibi single-photon emission computed tomography (SPECT). Am J Cardiol 1997;79:1319–1322.

    Article  PubMed  CAS  Google Scholar 

  54. Abidov A, Hachamovitch R, Hayes SW, et al. Prognostic impact of hemodynamic response to adenosine in patients older than age 55 years undergoing vasodilator stress myocardial perfusion study. Circulation 2003;107:2894–2899.

    Article  PubMed  Google Scholar 

  55. Staniloff HM, Forrester JS, Berman DS, Swan HJ. Prediction of death, myocardial infarction, and worsening chest pain using thallium scintigraphy and exercise electrocardiography. J Nucl Med 1986;27:1842–1848.

    PubMed  CAS  Google Scholar 

  56. Pryor DB, Harrell FE Jr, Lee KL, et al. Prognostic indicators from radionuclide angiography in medically treated patients with coronary artery disease. Am J Cardiol 1984;53:18–22.

    Article  PubMed  CAS  Google Scholar 

  57. Nallamothu N, Pancholy SB, Lee KR, Heo J, Iskandrian AS. Impact on exercise single-photon emission computed tomographic thallium imaging on patient management and outcome. J Nucl Cardiol 1995;2:334–338.

    Article  PubMed  CAS  Google Scholar 

  58. Bateman TM, O’Keefe JH Jr, Dong VM, et al. Coronary angiographic rates after stress single-photon emission computed tomographic scintigraphy. J Nucl Cardiol 1995;2:217–223.

    Article  PubMed  CAS  Google Scholar 

  59. Hachamovitch R, Johnson JR, Barrett RJ, Udelson JE. International patterns of referral to revascularization early after pharmacologic stress SPECT: results from a prospective multicenter registry trial [abstract]. Circulation 2004;110:III684.

    Google Scholar 

  60. Hachamovitch R, Shaw L, Berman DS. Methodological considerations in the assessment of noninvasive testing using outcomes research: pitfalls and limitations. Prog Cardiovasc Dis 2000;43:215–230.

    Article  PubMed  CAS  Google Scholar 

  61. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Stress myocardial perfusion SPECT is clinically effective and cost-effective in risk-stratification of patients with a high likelihood of CAD but no known CAD. J Am Coll Cardiol 2004;43:200–208.

    Article  PubMed  Google Scholar 

  62. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994;344:563–570.

    Article  PubMed  CAS  Google Scholar 

  63. Abidov A, Bax JJ, Hayes SW, et al. Integration of automatically measured transient ischemic dilation ratio into interpretation of adenosine stress myocardial perfusion SPECT for detection of severe and extensive CAD. J Nucl Med 2004;45(12):1999–2007.

    PubMed  CAS  Google Scholar 

  64. Sharir T, Berman DS, Waechter PB, et al. Quantitative analysis of regional motion and thickening by gated myocardial perfusion SPECT: normal heterogeneity and criteria for abnormality. J Nucl Med 2001;42:1630–1638.

    PubMed  CAS  Google Scholar 

  65. Lima RS W D, Goode AR, Siadaty MS, Ragosta M, Beller GA, Samady H. Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease. J Am Coll Cardiol 2003;42:64–70.

    Article  PubMed  Google Scholar 

  66. Hachamovitch R, Hayes SW, Friedman JD, et al. Is there a referral bias against revascularization of patients with reduced LV ejection fraction? Influence of ejection fraction and inducible ischemia on post-SPECT management of patients without history of CAD. J Am Coll Cardiol 2003;42:1286–1294.

    Article  PubMed  Google Scholar 

  67. Mark DB, Shaw L, Harrell FE, et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 1991;325:849–853.

    Article  PubMed  CAS  Google Scholar 

  68. Marwick TH, Shaw L, Case C, Vasey C, Thomas JD. Clinical and economic impact of exercise electrocardiography and exercise echocardiography in clinical practice. Eur Heart J 2003;24:1153–1163.

    Article  PubMed  CAS  Google Scholar 

  69. Kim C, Kwok YS, Saha S, Redberg RF. Diagnosis of suspected coronary artery disease in women: a cost-effectiveness analysis. Am Heart J 1999;137:1019–1027.

    Article  PubMed  CAS  Google Scholar 

  70. Imran MB, Khan MA, Aslam MN, Irfanullah J. Diagnosis of coronary artery disease by stress echocardiography and perfusion scintigraphy. J Coll Physicians Surg Pak 2003;13:465–470.

    PubMed  Google Scholar 

  71. Kuntz KM, Fleischmann KE, Hunink MG, Douglas PS. Cost-effectiveness of diagnostic strategies for patients with chest pain. Ann Intern Med 1999;130:709–718.

    PubMed  CAS  Google Scholar 

  72. Kim C, Kwok YS, Heagerty P, Redberg R. Pharmacologic stress testing for coronary disease diagnosis: a metaanalysis. Am Heart J 2001;142:934–944.

    Article  PubMed  CAS  Google Scholar 

  73. Kwok Y, Kim C, Grady D, Segal M, Redberg R. Metaanalysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999;83:660–666.

    Article  PubMed  CAS  Google Scholar 

  74. Diagnosis and treatment of coronary heart disease in women: systematic reviews of evidence on selected topics. Summary, evidence report/technology assessment: Number 81. Rockville MD: AHRQ Publication; 2003:No. 03-E036.

    Google Scholar 

  75. Results of systematic review of research on diagnosis and treatment of coronary heart disease in women. Summary, evidence report/technology assessment: Number 80. Rockville MD: AHRQ Publication; 2003:No. 03-E034.

    Google Scholar 

  76. Marwick TH, Case C, Vasey C, Allen S, Short L, Thomas JD. Prediction of mortality by exercise echocardiography: a strategy for combination with the Duke treadmill score. Circulation 2001;103:2566–2571.

    PubMed  CAS  Google Scholar 

  77. Chuah SC, Pellikka PA, Roger VL, McCully RB, Seward JB. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation 1998;97:1474–1480.

    PubMed  CAS  Google Scholar 

  78. Sicari R, Pasanisi E, Venneri L, Landi P, Cortigiani L, Picano E. Stress echo results predict mortality: a largescale multicenter prospective international study. J Am Coll Cardiol 2003;41:589–595.

    Article  PubMed  Google Scholar 

  79. Cortigiani L, Picano E, Landi P, et al. Value of pharmacologic stress echocardiography in risk stratification of patients with single-vessel disease: a report from the Echo-Persantine and Echo-Dobutamine International Cooperative Studies. J Am Coll Cardiol 1998;32:69–74.

    Article  PubMed  CAS  Google Scholar 

  80. Shaw LJ, Vasey C, Sawada S, Rimmerman C, Mariwck TH. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long term mortality in 4234 women and 6898 men. Eur Heart J 2005;26(5):447–456.

    Article  PubMed  Google Scholar 

  81. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002;106:1883–1892.

    Article  PubMed  Google Scholar 

  82. Chung G, Krishnamani R, Senior R. Prognostic value of normal stress echocardiogram in patients with suspected coronary artery disease: a British general hospital experience. Int J Cardiol 2004;94:181–186.

    Article  PubMed  Google Scholar 

  83. Yao SS, Qureshi E, Sherrid MV, Chaudhry FA. Practical applications in stress echocardiography: risk stratification and prognosis in patients with known or suspected ischemic heart disease. J Am Coll Cardiol 2003;42:1084–1090.

    Article  PubMed  Google Scholar 

  84. Elhendy A, Mahoney DW, Khandheria BK, Paterick TE, Burger KN, Pellikka PA. Prognostic significance of the location of wall motion abnormalities during exercise echocardiography. J Am Coll Cardiol 2002;40:1623–1629.

    Article  PubMed  Google Scholar 

  85. Lorenzoni R, Cortigiani L, Magnani M, et al. Cost-effectiveness analysis of noninvasive strategies to evaluate patients with chest pain. J Am Soc Echocardiogr 2003;16:1287–1291.

    Article  PubMed  Google Scholar 

  86. Marwick TH, Anderson T, Williams MJ, et al. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol 1995;26:335–341.

    Article  PubMed  CAS  Google Scholar 

  87. Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? A meta-analysis of diagnostic test performance. JAMA 1998;280:913–920.

    Article  PubMed  CAS  Google Scholar 

  88. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 2003;107:149–158.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Keck School of Medicine, U.S.C., Los Angeles, CA, USA

    Rory Hachamovitch MD, MSc

  2. Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Leslee J. Shaw PhD & Daniel S. Berman MD, FACC

Authors
  1. Rory Hachamovitch MD, MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leslee J. Shaw PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniel S. Berman MD, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Royal Brompton Hospital, London, UK

    Constantinos D Anagnostopoulos MD, PhD, FRCR, FESC

  2. Chelsea & Westminster Hospital, London, UK

    Constantinos D Anagnostopoulos MD, PhD, FRCR, FESC

  3. Imperial College School of Medicine, National Heart and Lung Institute, London, UK

    Constantinos D Anagnostopoulos MD, PhD, FRCR, FESC

  4. Hammersmith Hospital, Imperial College, London, UK

    Petros Nihoyannopoulos MD, FRCP, FACC, FESC

  5. Leiden University Medical Center, Leiden, The Netherlands

    Jeroen J. Bax MD, PhD  & Ernst van der Wall MD, FESC, FACC  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag London Limited

About this chapter

Cite this chapter

Hachamovitch, R., Shaw, L.J., Berman, D.S. (2006). Prognostic Assessment by Noninvasive Imaging. Part a. Clinical Decision-making in Patients with Suspected or Known Coronary Artery Disease. In: Anagnostopoulos, C.D., Nihoyannopoulos, P., Bax, J.J., van der Wall, E. (eds) Noninvasive Imaging of Myocardial Ischemia. Springer, London. https://doi.org/10.1007/1-84628-156-3_11

Download citation

  • DOI: https://doi.org/10.1007/1-84628-156-3_11

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-027-6

  • Online ISBN: 978-1-84628-156-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation